BioRem Inc. (BRM.V)
| Previous Close | 0.8000 |
| Open | 0.7550 |
| Bid | 0.7500 x 0 |
| Ask | 0.8000 x 0 |
| Day's Range | 0.7550 - 0.8200 |
| 52 Week Range | 0.6600 - 0.9900 |
| Volume | |
| Avg. Volume | 2,153 |
| Market Cap | 12.382M |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 16.00 |
| EPS (TTM) | 0.0500 |
| Earnings Date | Nov 23, 2022 - Nov 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
New growth initiatives drive BIOREM order backlog to record $44.5M
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $7.1 million. The orders are for air emission abatement projects in North America and continue to increase BIOREM's order backlog to a record $44.5 million, its highest point since the Company was founded in 1990.
- CNW Group
Biorem Reports Second Quarter Results & Record Order Backlog
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2022. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
- CNW Group
BIOREM order backlog grows to $40-million on strength of $11-million in new orders
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced $11-million of new orders for air emission abatement projects in North America. This brought the company's order backlog to a record $40-million, its highest point since the company was founded in 1990.
